Benchmark International Logo Blog Mergers and Acquisitions

Archives

Benchmark International Advises on the Sale of Waste Check Limited to Reconomy Limited

Benchmark International has successfully facilitated the sale of Waste Check Limited to Reconomy Limited.

Waste Check is a waste broker and management company specialising in the disposal of clinical and chemical waste materials for companies operating in numerous business sectors.

The acquirer, Reconomy, is a recycling and waste management service provider to the house building, commercial construction, infrastructure, and business & industry sectors. It was identified as an excellent fit for Waste Check, as it has allowed Reconomy to diversify into general and hazardous waste.

Reconomy has also been hot on the acquisition trail, acquiring companies in both 2015 and 2016, and through this and organic business growth the company achieved a revenue of £118m in 2016 and is predicting revenues of £135m by the end of 2018.

 

Ready to explore your exit and growth options?

 

Chief Executive of Reconomy, Paul Cox, said: “This is an important acquisition for Reconomy, which enables us to extend our waste management offering into a broader range of industries and commercial sectors. We will continue to expand our business portfolio and invest in the companies we acquire to enhance both their technological and waste reporting capabilities. This will help ensure our customers receive the best possible service. Waste Check is a family-run business with an established reputation for delivering excellent customer service, so its culture will align very well with that of Reconomy. We are looking forward to a long and prosperous future together.” 

Commenting on the process, Mark Jenkins, director and shareholder at Waste Check said: “The support, direction and advice you [Benchmark International] gave us from all areas of your business was first class and professionally delivered. We would not have been able to conclude the deal at such a high value without the input of your entire team. The feeling of elation at completion was something we will always remember. A truly great decision we took to sell our company supported by a truly professional and knowledgeable team. We thank you all so much for the way you realised our dream after 10 years to sell Waste Check as a going concern, which will see it flourish further under its new owners in the waste management industry.”

Benchmark International would like to thank all parties involved and we wish them all the very best of luck for the future.

Reconomy website: https://www.reconomy.com/services/skip-hire  

READ MORE >>

You Need an M&A Specialist, Not an Industry Expert

It’s time to dispel the myth that it’s better to use an industry expert versus a mergers and acquisitions expert for the sale of a business. At times, sellers are apprehensive about engaging with a mergers and acquisitions firm that doesn’t specialize in one specific industry, and they say they would rather use an industry expert instead. This isn’t the best strategy for a seller who hopes to gain the most value for his or her business.

The mergers and acquisitions cycle is constantly changing. That’s why it’s important for mergers and acquisitions firms to stay on top of industry trends and stay abreast of any new developments. At Benchmark International, we are M&A professionals who work in all industries. Our business is selling businesses, and we understand the industry specifics.

READ MORE >>

Benchmark International expands in Tennessee

Benchmark International is delighted to announce our expansion into Nashville, Tennessee. Nashville has become a hotbed of mergers and acquisitions activity, and it is one of the fastest growing cities in the US.

Additionally, Benchmark International is growing exponentially, with four new regional offices opened domestically and internationally. So, it was only logical for Benchmark International to expand to this territory and be a part of this growing business culture.

READ MORE >>

Thomson Reuters Ranks Benchmark International as One of the Worlds Top 50 M&A Companies

Thomson Reuters released their review of the mid-market mergers and acquisitions industry for 2017. In this report is a list of the worldwide mid-market rankings for companies that completed deals valued up to $500 million. Benchmark International is pleased to be listed in the top 50, worldwide, for M&A deals valued up to $500 million. Businesses named on this list include KPMG, Ernst & Young, LLP Deloitte, Goldman Sachs & Co., JP Morgan, Morgan Stanley, amongst others. With the distinction of being listed in the same category as M&A industry giants, Benchmark International is showing we are an invaluable asset to any business owner looking to exit his or her business.

READ MORE >>

Going for Gold – Benchmark International Achieves Medal Worthy Positions on Pro-Manchester’s ‘Most Active Advisers’ List

It may be the bleak midwinter for some, although for others it marks a four year long wait for the Winter Olympics which, for 2018, is being held in PyeongChang, South Korea, between the 9th February and 25th February.

It just so happens that this has coincided with the annual Corporate Finance Review for 2017, presented by Pro-Manchester, the largest business development organisation in the North West that represents business communities across the region, in association with Experian MarketIQ – a UK business database provider.

The review’s aim is to give insight into Manchester’s corporate finance market, examining the deals that Manchester-based advisers have worked on. This has shown that Benchmark International is giving Team GB a run for its money with it gaining all three medal table positions in the (cool) runnings for Manchester’s ‘Most Active Financial Adviser’ of 2017.

In gold place was Peter Kelly, who advised on a remarkable 25 deals in 2017. In second place, and gaining the silver medal, was Nick Hulme; and in joint third place was Roger Forshaw, who brought in the bronze for Benchmark International.

READ MORE >>

Benchmark International Advises on the Sale of Atlanta Biologicals, Inc. to Bio-Techne Corporation

Posted on February 6, 2018 By in Atlanta + Deal completions + Success + Biologicals

Benchmark International has successfully facilitated the stock sale of Atlanta Biologicals, Inc., and its affiliated company Scientific Ventures, to the Bio-Techne Corporation (NASDAQ: TECH). The transaction is financed through available cash on hand.

Charles R. Kummeth, President and Chief Executive Officer of Bio-Techne, commented, "Atlanta Biologicals is a great fit with the Bio-Techne product portfolio as we continue to expand our cell culture and tissue regeneration capabilities. Many of our products are used in tissue culture applications and the Atlanta Biologicals fetal bovine serum (FBS) product line strengthens and complements our current tissue culture reagents offering and furthers our efforts to provide more complete solutions to our research customers. With the increasing interest in 3D cell cultures and other cell based clinical applications, we believe there is value in providing customers alternative and reliable sources of high quality FBS and other tissue culture reagents. Having better tools to study cell behavior in physiologically relevant environments and high quality reagents increases researchers' confidence in the experimental findings.“

Atlanta Biologicals President, Renate Gerle, added, “We are confident with the strategic fit between the two companies given our shared commitment to providing quality products and excellent customer service. Atlanta Biologicals is pleased to have Bio-Techne as a partner, enabling us to expand and enhance our products offering. Bio-Techne's resources and additional market channels will have a positive impact on our business and allow us to serve our customers more efficiently both in the North America and globally.

I would also like to take a moment and thank Benchmark International for their expertise throughout the sale. Naturally, selling a business is a major step, but Benchmark made it a truly seamless process. We had spoken with a number of industry specialist prior to engaging Benchmark; however, Benchmark’s proven ability to negotiate the best deal, their structured team approach, their numerous resources to attract both domestic and international buyers paired with their in-depth knowledge about our industry ultimately determined our decision. I will admit, I was very apprehensive when we first started but Benchmark made the process smoother than expected. They were taking an active lead from start to finish and ultimately delivered the best results we could hope for. I was surprised and impressed by the amount and quality of buyers brought to the company and how all aspects of every potential opportunity were evaluated to achieve the best outcome for the owner and the company. Looking back, I clearly feel industry specialist would not have been able to provide us with this extent of options and analysis. Hearing about the process upfront and then watching it become implemented in real-time reinforces that engaging Benchmark was the best decision and fit we could have made to sell the business. My advice to any owner who genuinely wants to achieve the best results would be to engage with a global specialist like Benchmark rather than over-focusing on industry buyers.”

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteins––notably cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds --- which are sold to biomedical researchers and clinical research laboratories; these operations constitute the core Biotechnology Division, headquartered in Minneapolis, Minnesota.

Atlanta Biologicals was founded in 1992 and has focused on supplying cell culture sera, media and reagents for the life science research market. It is located in Flowery Branch, Georgia and has approximately 25 employees. The acquisition is expected to be slightly accretive to Bio-Techne's adjusted earnings per share for its fiscal year 2018.

READ MORE >>

Silexx Client Testimonial {video}

Posted on February 6, 2018 By in Client Testimonials + Technology + reviews

Benchmark International is delighted to announce the sale of Silexx to the Chicago Board of Exchange.

READ MORE >>

Label Express Ltd Client Testimonial {video}

  READ MORE >>

A Glimpse into Enterprise Resource Planning in M&A

In the technological and global communication era we live in today, it’s no wonder that 2018 seeks to be the year of technology-based mergers and acquisitions. Corporate and private equity leaders have voiced plans for technology acquisitions at the top of their priority list this year. One market which appears to be growing rapidly and playing a more integrated role in mergers and acquisitions is enterprise resource planning (ERP).

READ MORE >>
1

Subscribe to Email Updates

Recent Posts

Follow Us on Twitter